Efficacy and Safety of Leflunomide for Refractory COVID-19: An Open-label Controlled Study

Qiang Wang, Haipeng Guo, Yu Li, Xiangdong Jian, Xinguo Hou, Ning Zhong, Jianchun Fei, Dezhen Su, Zhouyan Bian, Yi Zhang, Yingying Hu, Yan Sun, Xueyuan Yu, Yuan Li, Bei Jiang, Yan Li, Fengping Qin, Yingying Wu, Yanxia Gao, Zhao Hu
doi: https://doi.org/10.1101/2020.05.29.20114223

Data Availability

After publication, study data will be available on reasonable request to the corresponding author.

Back to top
Posted June 02, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Efficacy and Safety of Leflunomide for Refractory COVID-19: An Open-label Controlled Study
Qiang Wang, Haipeng Guo, Yu Li, Xiangdong Jian, Xinguo Hou, Ning Zhong, Jianchun Fei, Dezhen Su, Zhouyan Bian, Yi Zhang, Yingying Hu, Yan Sun, Xueyuan Yu, Yuan Li, Bei Jiang, Yan Li, Fengping Qin, Yingying Wu, Yanxia Gao, Zhao Hu
medRxiv 2020.05.29.20114223; doi: https://doi.org/10.1101/2020.05.29.20114223
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area